Literature DB >> 30193543

Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis.

Jianmei Pan1, Xiaohua Zhang2, Yongjun Shi2, Qingshan Pei2.   

Abstract

OBJECTIVE: There are no guidelines or consensus on the optimal treatment measures for small rectal neuroendocrine tumors (NETs) at present. This meta-analysis was conducted to compare the efficacy and safety of endoscopic mucosal resection (EMR) with suction and endoscopic submucosal dissection (ESD) for the small rectal NETs.
METHODS: The literature searches were conducted using Pubmed and Embase databases, and then a meta-analysis was performed. The primary outcome was complete resection rate, and the secondary outcomes were complication rate, procedure time, and recurrence rate.
RESULTS: Fourteen studies with 823 patients were included in our meta-analysis. The overall complete resection rates in EMR with suction and ESD procedure were 93.65% (472/504) and 84.08% (243/289), respectively. The pooled analysis showed that EMR with suction could achieve a higher complete resection rate than ESD with significance (OR: 4.08, 95% CI: 2.42-6.88, p < .00001) when the outlier study was excluded, and procedure time was significantly shorter in the EMR with suction group than in the ESD group (SMD: -1.59, 95% CI: -2.27 to -0.90, p < .00001). Moreover, there was no significant difference in overall complication rate (OR: 0.56, 95% CI: 0.28-1.14, p = .11) and overall recurrence rate (OR: 0.76, 95% CI: 0.11-5.07, I2=48%) between EMR with suction and ESD group.
CONCLUSIONS: The present meta-analysis mostly based on retrospective studies show that EMR with suction is superior to ESD for small rectal NETs (≤10 mm) with higher complete resection rate, shorter procedure time, and similar overall complication rate and recurrence.

Entities:  

Keywords:  Endoscopic mucosal resection; endoscopic submucosal dissection; rectal carcinoid tumor; rectal neuroendocrine tumor

Mesh:

Year:  2018        PMID: 30193543     DOI: 10.1080/00365521.2018.1498120

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Risk Factors for Development of Rectal Neuroendocrine Tumors Longer Than 9 mm: Retrospective Cohort.

Authors:  Juliana Silveira Lima de Castro; Evandra Cristina Vieira da Rocha; Vanessa Assis do Vale; Paula Mendonça; Oswaldo Wiliam Marques; Eloy Taglieri; Francisco Susumu Correa Koyama; Celso Augusto Milani Cardoso Filho; Wilson Toshihiko Nakagawa
Journal:  Turk J Gastroenterol       Date:  2021-08       Impact factor: 1.852

Review 2.  Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.

Authors:  Johannes Hofland; Gregory Kaltsas; Wouter W de Herder
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 3.  Management of Gastrointestinal Neuroendocrine Tumors.

Authors:  Rongzhi Wang; Rui Zheng-Pywell; H Alexander Chen; James A Bibb; Herbert Chen; J Bart Rose
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-10-24

Review 4.  Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.

Authors:  Camilla Gallo; Roberta Elisa Rossi; Federica Cavalcoli; Federico Barbaro; Ivo Boškoski; Pietro Invernizzi; Sara Massironi
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

Review 5.  Endoscopic treatment for rectal neuroendocrine tumor: which method is better?

Authors:  Seung Min Hong; Dong Hoon Baek
Journal:  Clin Endosc       Date:  2022-07-11

6.  Comparison of endoscopic submucosal resection with ligation and endoscopic submucosal dissection for small rectal neuroendocrine tumors: A multicenter retrospective study.

Authors:  Kenshi Matsuno; Hideaki Miyamoto; Hideki Kitada; Shinichi Yoshimatsu; Fumio Tamura; Kouichi Sakurai; Kotaro Fukubayashi; Takashi Shono; Hiroko Setoyama; Taichi Matsuyama; Shinichiro Suko; Rei Narita; Munenori Honda; Masakuni Tateyama; Hideaki Naoe; Jun Morinaga; Yasuhito Tanaka; Ryosuke Gushima
Journal:  DEN open       Date:  2022-09-15

7.  Endoscopic mucosal resection: still a reliable therapeutic option for gastrointestinal neuroendocrine tumors.

Authors:  Gholam Reza Sivandzadeh; Fardad Ejtehadi; Shima Shoaee; Ladan Aminlari; Ramin Niknam; Ali Reza Taghavi; Bita Geramizadeh; Ahmad Hormati; Ali Reza Safarpour; Kamran Bagheri Lankarani
Journal:  BMC Gastroenterol       Date:  2021-05-24       Impact factor: 3.067

8.  Anchoring the snare tip is a feasible endoscopic mucosal resection method for small rectal neuroendocrine tumors.

Authors:  Jeongseok Kim; Jisup Kim; Eun Hye Oh; Nam Seok Ham; Sung Wook Hwang; Sang Hyoung Park; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Suk-Kyun Yang; Seung-Mo Hong; Dong-Hoon Yang
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  Effects of endoscopic submucosal dissection on post-operative early treatment effectiveness and serum TAT-2 and GP73 expression levels in patients with early gastric cancer.

Authors:  Xue Huang; Fujian Liu; Hang Guan; Zhiyong Jiang; Peng Wei; Yifeng Luo; Qiuhong Jia
Journal:  Exp Ther Med       Date:  2021-05-27       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.